“On TV & Video” is a column exploring opportunities and challenges in advanced TV and video. Today’s column is by Marcella Milliet Sciorra, CMO of DeepIntent. Linear TV has long dominated the marketing mix for pharmaceutical brands and their agencies. In 2021, these groups spent an estimated $ 3.9 billion on national broadcast and cable ads,… Continue reading »
The post Linear Is Still The King Of Pharma, But For How Long? appeared first on AdExchanger.
More Stories
oOh!media backs YouthLine ‘Walk the Talk’ fundraiser
Air New Zealand wins March Kantar Ad Impact Award
Tegel gets heads bobbing with dentsu Aotearoa